Oxatomide in the Treatment of Chronic Urticaria
作者:
W. Peremans,
R.L.J. Mertens,
J. Morias,
H. Campaert,
期刊:
Dermatology
(Karger Available online 1981)
卷期:
Volume 162,
issue 1
页码: 42-50
ISSN:1018-8665
年代: 1981
DOI:10.1159/000250232
出版商: S. Karger AG
关键词: Allergy;Chronic urticaria;Oxatomide
数据来源: Karger
摘要:
Oxatomide was evaluated in a double-blind study of 35 patients with chronic urticaria. For 5 weeks patients received at random either 30 mg oxatomide b.i.d. or a placebo. Oxatomide significantly reduced not only the duration of the attacks but also the severity of erythema, lesions and itching. This lower level of suffering was clearly reflected by a diminished need for additional antiallergic medication. The overall response to treatment was rated excellent or good in 72% of the oxatomide-treated patients against only 23% of the controls which is a significant difference. Sleepiness was reported in 1 patient of each group.
点击下载:
PDF
(1458KB)
返 回